Real-World Data (RWD) & Life Science Analytics Congress to be Held in Boston, United States on 25 - 26 October 2018

Top Quote Our aim at the Real-World Data & Life Science Analytics s to bring these two worlds together to understand how to leverage traditional data sets and layer that in with RWE, the operating models for both and analytic capabilities necessary to achieve clinical development. End Quote
  • Boston, MA-NH (1888PressRelease) October 24, 2018 - Markets and Markets is all set to present an event to discuss the innovative alliance of Real-World Data & Life Science Analytics Congress for the prosperous future of the healthcare industry. It’s a great platform to discover the significance of Real World Evidence (RWE) in healthcare.

    Speakers in the event will converge and talk on a range of topics, focusing on the need for RWD and how it plays an important role in improving the lives of patients and clinical trials.

    Healthcare organizations are entering into the leading-edge world of value-based payments hence they need to embrace the enhanced analytics to identify the potential benefits and risks and improving the quality of clinical performance. However, there are a few risks involved as they are uncertain about where to start, which tools to use and how effective it is.

    RWE is a burgeoning field and there is no better time like now to get started. It has a tremendous potential to provide valuable insights into treatment decisions. Researchers, analysts, physicians, clinicians, regulators, pharmaceuticals and healthcare professionals, insurance companies can come and attend the brainstorming sessions to learn the elevation in this field.

    Event Venue:

    Real-World Data & Life Science Analytics Congress will be held at:
    Holiday Inn Boston-Brookline
    1200 Beacon Street, Brookline, Massachusetts, 02446, United States

    Key Highlights of the Event:

    The prime objective of the event is to bring the world together for the betterment in healthcare. The attendees will get to know about:

    • An explosion of data availability
    • Data Expansion
    • Limitations of RWE
    • Different uses of real-world evidence data
    • Clinical uses of RWE
    • Payers perspective
    • RWE and patient-centric data in non-clinical settings
    • Clinical trial optimization
    • Machine learning algorithms
    • Novel analytical tools
    • Health economics and outcomes research
    • Governance and compliance
    • Data security and privacy
    • Patient models for effective use of analytics
    • Integrating artificial intelligence
    • Advanced and intelligent analytics

    ###
space
space
  • FB Icon Twitter Icon In-Icon
Contact Information